Microalgae and Age-Related Diseases: New Innovative Approaches to Age-Old Problems

Dear Colleagues,

Today, an increasing number of individuals are impacted by long-term chronic illnesses, such as cardiovascular and/or neurodegenerative disorders, diabetes, hypertension, liver disease, and chronic kidney disease, among others, which are all highly associated with the aging process. Despite the advances in therapeutic approaches made in recent years, age-related ailments continue to pose a significant risk to human health. Therefore, it is crucial to create innovative treatment methods, including the development of new medications.

Microalgae are a vast and largely untapped resource, with a plethora of novel biomolecules derived from their biomass. These include carotenoids, antioxidants, polyphenols, fatty acids, enzymes, polymers, peptides, and sterols. These biologically active substances have the potential to exhibit antioxidant, anti-inflammatory, antibacterial, antiviral, antitumor, regenerative, antihypertensive, neuroprotective, and immunostimulating effects, making them crucial to the biomedical and pharmaceutical industries.

This Special Issue seeks to gather fresh and compelling high-quality manuscripts, such as research articles and comprehensive reviews, that focus on age-related diseases and the use of therapies utilizing biomolecules and extracts derived from microalgae. Studies involving human subjects or animal models are permissible.

Dr. D. Craig Willcox
Dr. Richard C. Allsopp
Dr. Bradley Willcox
Dr. Giovanni Scapagnini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• microalgae
• age-related diseases
• polyphenols
• inflammation
• new approaches